NewAmsterdam Pharma Company NV Ordinary Shares

Price & Volume

Stats

See more
52W Range
$14.06-$42
Market Cap
$3.5B
Shares Short
6M

Financials

See more
Revenue (12 Mos)
$22.5M
Revenue Growth (YoY)
-99.8%
Gross Profit (12 Mos)
$22.5M
Diluted EPS
-$1.72

About

CEO
Dr. Michael Harvey Davidson FACC, Facp., M.D.
Address
Gooimeer 2-35, Naarden, Netherlands, 1411 DC
Sector
Healthcare
Industry
Biotechnology
Full-Time Employees
100